Dinoprostone shortage: a shift to DILAPAN-S in maternity units

Supply disruptions can have a real impact on induction pathways. This article from AGHealth highlights how UK maternity units are adapting to the current shortage of commonly used PGE-based options. In this context, some units may consider non-pharmacological methods for cervical ripening, depending on local protocols and clinical judgement.

Real-world transition from dinoprostone to DILAPAN‑S

Dr Jill Sturt and Claire Cameron share their experience of moving from dinoprostone gel to DILAPAN-S as a frontline cervical ripening method at QE Gateshead NHS Foundation Trust.

“I’ll be completely honest — it has completely changed my opinion of DILAPAN-S.”

‍Watch this 2-minute highlight video of the transition from PGE2 to DILAPAN-S:

For more context, you can watch the full webinar recording here:

‍